D-Eye Srl names Galileo Diagnostics, commercial branch of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
D-Eye Srl names Galileo Diagnostics, commercial branch of Genclis SA, international distributor for Veterinary Market

NANCY, France and PADOVA, Italy and PASADENA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- D-Eye, a leading developer of advanced devices for mass health screenings and data analytics, and Genclis, a molecular diagnostic company based in Nancy, France, announced today their strategic partnership for the international distribution (excluding North and South America) of D-Eye products for the veterinary medicine market.

Genclis' commercial branch, Galileo Diagnostics, will distribute the innovative D-Eye Portable Retinal Imaging System .  The advanced, affordable retinal examiner, is a phone-case-sized add-on that turns an iPhone or Android smartphone into a fundus camera capable of taking high-definition video and still images of the eye for screening and evaluating the vision health of pets, small animals, horses, birds and other species.

" Galileo Diagnostics is one of the most active and respected distributors of animal health care products in Europe, the Middle East, Asia and Africa ," said D-Eye CEO Richard Sill.  " Their visibility and renown within the international veterinary medical market will serve us well as we seek to introduce the benefits of the ground-breaking D-Eye Portable Retinal Imaging System to veterinarians, animal hospitals and specialty clinics around the world ."

The only truly portable ophthalmoscope capable of digitally imaging the fundus of the eye, the low-cost D-Eye device simply attaches to a smartphone (Apple iOS or Android), positioned over the phone's camera lens and LED light source, enabling the phone to capture high-definition video and still images of the interior of the eye.  A D-Eye software app installed on the smartphone provides step-by-step instructions and archives all examinations on a patient chart for convenient file management.    

" The D-Eye product offers veterinary doctors a remarkably affordable, portable and easy-to-use tool to examine the retina ," according to Pascale Bihain, Executive Vice-President, Galileo Diagnostics by Genclis.  " We are excited to be working with the D-Eye team to bring this new technology to the international animal care market. Working with leading veterinary ophthalmologists, we have confirmed the product's effectiveness on dogs, cats, rabbits, and other pets and small animals, as well as horses.  D-Eye has the potential to revolutionize how vets screen for disorders and diseases of the eye ."

For more information about availability of the D-Eye Portable Retinal Imaging System, please contact
Galileo Diagnostics at + 33 3 83 67 82 17.

About Galileo Diagnostics:

Galileo Diagnostics, a branch of Genclis SA, designs, develops and markets a complete range of solutions for veterinary allergies and other veterinary health conditions, providing ready-to-use, high-reliability products for the diagnosis and treatment of pets and other animals. Galileo's lead proprietary products are CynoDial and FeliDial, two breakthrough innovations that help veterinarians to find solutions for animals with severe symptoms of food allergies.  Galileo Diagnostics also distributes third-party products, notably innovative connected devices.  For more information on Galileo Diagnostics, please visit www.galileodiagnostics.com or call (in France) +33 6 89 26 58 97, +33 3 83 67 82 17, or +33 3 83 57 46 51 (fax).

About Genclis:

Genclis is a molecular diagnostic company in the fields of allergy and cancer. Started in 2004, the Company initiated the commercialization of its allergy molecular diagnostic tests in 2014. In the field of cancer diagnostics, Genclis based its development on the concept of DNA/RNA divergences due to transcription infidelity, an original, proprietary disruptive science. This science has already led to encouraging results in the severity prognostic of triple negative breast cancer ("TNBC"), a severe form of breast cancer. Genclis intends to rapidly impose its solution, Severidia©, as a standard for oncologists to offer their patients alternative treatment and monitoring options.  Based in Nancy and Paris, Genclis had 45 employees as of February 1, 2015.  Please visit: www.genclis.com

About D-Eye:

Founded in 2014, with offices in Padova, Italy, Pasadena, CA, and Boston, MA, D-Eye Srl offers a "digital eye" into the state of the human body.  We design and manufacture mobile sensing and examination devices, along with companion applications, that enable mass health screenings and data collection to improve access to vital health examination services.  We also develop and operate cloud-based Platform-as-a-Service (PaaS) systems that enable telehealth applications by aggregating health screening data.  Our first product, the revolutionary D-Eye Portable Retinal Imaging System, focuses on eye care; subsequent mobile-health products and services will target screening and evaluation of other medical conditions and pathologies.  D-Eye was developed by Si14 SpA, a visionary original design and development laboratory for novel technology products that enhance the way we live, work and play.  For more information, please visit www.D-Eyecare.com  or call 01-626-497-9212 (US) or +39 049 7811 860 (Italy).
#     #     #

Media Contact:

For D-Eye                                                                                           For Galileo Diagnostics by Genclis
Jim White                                                                                         Pascale Bihain
VP Marketing and Communications                                                     Executive Vice-President
Tel: 01 626 840 3796 (US mobile)                                                       Tel: +33 6 89 26 58 97
jim.white@D-Eyecare.com                                                                  pbihain@genclis.com

www.D-Eyecare.com                                                                         www.galileodiagnostics.com

For Genclis
Bernard Bihain                    Stéphane Boissel                        Press relations: ATCG Presse
Chairman and CSO                CEO                                             Judith Aziza
Tel: +33 6 33 02 90 88           Tel: +33 6 74 78 09 25                    Tél: +33 6 70 07 77 51
bbihain@genclis.com               sboissel@genclis.com                       presse@atcg-partners.com

www.genclis.com

PR Galileo by Genclis http://hugin.info/164309/R/1904674/677606.pdf

HUG#1904674

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 104

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 107

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 81

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 79

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading

Top 5 Most Recently Viewed Articles

Larry Chen's Transformative Journey in Automotive Photography

Updated Category News Views 460

Celebrating 20 Years of Automotive Photography Renowned automotive photographer Larry Chen presents his first-ever book titled Life at Shutter Speed: Two Decades of Larry Chen Photography. This extensive 400-page work features exceptional highlights from Chen's impressive career, along with captivating never-before-seen images. What’s Inside the Book? Life at Shutter...

Continue Reading
Kemper Corporation Achieves Record Stock High of $71.71

Updated Category News Views 157

Kemper Corporation Achieves New Stock Milestone Kemper Corporation (NYSE: KMPR) has reached an impressive milestone by achieving a remarkable 52-week high of $71.71. This achievement not only signifies a substantial uptrend for the diversified insurance holding but also reflects a commendable 67.95% increase in its stock value over the past year. The rising confidence...

Continue Reading
Rising Online Vaping Markets: A Challenge for Local Stores

Updated Category News Views 114

Challenges Faced by Local Convenience Stores in Quebec Local convenience stores in Quebec are confronting significant challenges due to the rise of online vaping sales. As these businesses grapple with a ban on flavored vapor products, introduced by Health Minister Christian Dubé, they are witnessing a shift in consumer behavior. This change has driven many customers to...

Continue Reading
Krispy Kreme Shareholders Invited to Join Class Action Lawsuit

Updated Category News Views 485

Krispy Kreme Investors: The Class Action Lawsuit Explained Krispy Kreme, Inc. (NASDAQ: DNUT) is facing a class action lawsuit that is generating significant attention among investors. This suit has been initiated by Robbins LLP following concerns about misleading statements made by the company's executives regarding its partnership with McDonald's. For anyone invested in...

Continue Reading
DexCom, Inc. Class Action Notice: Your Chance to Join Efforts

Updated Category News Views 62

Important Warning for DexCom, Inc. Shareholders Investors holding shares of DexCom, Inc. (NASDAQ: DXCM) should be aware of a critical opportunity to engage in a class action lawsuit. This notice emphasizes the essential details for shareholders who purchased shares during the specified class period. Your Participation Matters Shareholders are urged to reach out promptly...

Continue Reading